These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 233764)
21. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. Bini A; Fenoglio JJ; Mesa-Tejada R; Kudryk B; Kaplan KL Arteriosclerosis; 1989; 9(1):109-21. PubMed ID: 2643421 [TBL] [Abstract][Full Text] [Related]
23. Low-density lipoprotein concentration in interstitial fluid from human atherosclerotic lesions. Relation to theories of endothelial damage and lipoprotein binding. Smith EB; Ashall C Biochim Biophys Acta; 1983 Dec; 754(3):249-57. PubMed ID: 6197091 [TBL] [Abstract][Full Text] [Related]
24. Fibrinogen, fibrin and the arterial wall. Smith EB Eur Heart J; 1995 Mar; 16 Suppl A():11-4; discussion 14-5. PubMed ID: 7796823 [TBL] [Abstract][Full Text] [Related]
25. Lipids and plasma fibrinogen: early and late composition of the atherosclerotic plaque. Smith EB Cardiologia; 1994 Dec; 39(12 Suppl 1):169-72. PubMed ID: 7634262 [TBL] [Abstract][Full Text] [Related]
26. Repair in arterial tissue. Demonstration of fibrinogen/fibrin in the normal and healing rabbit thoracic aorta by the indirect immunoperoxidase technique. Chemnitz J; Christensen BC Virchows Arch A Pathol Anat Histopathol; 1984; 403(2):163-71. PubMed ID: 6426160 [TBL] [Abstract][Full Text] [Related]
27. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin. Müllertz S Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470 [TBL] [Abstract][Full Text] [Related]
28. [Atherogenic modifications of low density lipoproteins during fibrin formation and fibrinolysis]. Chulkova TM Vopr Med Khim; 1989; 35(2):72-5. PubMed ID: 2741416 [TBL] [Abstract][Full Text] [Related]
29. Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin. McKee PA; Mattock P; Hill RL Proc Natl Acad Sci U S A; 1970 Jul; 66(3):738-44. PubMed ID: 5269236 [TBL] [Abstract][Full Text] [Related]
30. Quantitative immunochemical determination of degradation products of fibrinogen and-or fibrin with high voltage electrophoresis. Niléhn JE Scand J Haematol Suppl; 1971; 13():215-7. PubMed ID: 5290683 [No Abstract] [Full Text] [Related]
31. The participation of aortic proteins in the formation of complexes between low density lipoproteins and intima-media extracts. Camejo G; Lopez A; Vegas H; Paoli H Atherosclerosis; 1975; 21(1):77-91. PubMed ID: 1131302 [TBL] [Abstract][Full Text] [Related]
32. Does lipoprotein(a) (Lp(a)) complete with plasminogen in human atherosclerotic lesions and thrombi? Smith EB; Crosbie L Atherosclerosis; 1991 Aug; 89(2-3):127-36. PubMed ID: 1838924 [TBL] [Abstract][Full Text] [Related]
33. Increase in fibrinogen and fibrin-related antigen in human serum due to in vitro lysis of fibrin by thrombin. Merskey C; Johnson AJ; Lalezari P J Clin Invest; 1972 Apr; 51(4):903-11. PubMed ID: 5014617 [TBL] [Abstract][Full Text] [Related]
34. Measurement of soluble fibrin monomer-fibrinogen complex in plasmas derived from patients with various underlying clinical situations. Nakahara K; Kazahaya Y; Shintani Y; Yamazumi K; Eguchi Y; Koga S; Wada H; Matsuda M Thromb Haemost; 2003 May; 89(5):832-6. PubMed ID: 12719780 [TBL] [Abstract][Full Text] [Related]
35. [Quantitative study on fibrinogen, fibrin in human aorta using single radial immunodiffusion method (author's transl)]. Mori K Nihon Ronen Igakkai Zasshi; 1979 Nov; 16(6):556-68. PubMed ID: 119078 [No Abstract] [Full Text] [Related]
36. Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis. Smith EB Clin Haematol; 1986 May; 15(2):355-70. PubMed ID: 3524931 [TBL] [Abstract][Full Text] [Related]
37. Fibrinolysis and plasminogen concentration in aortic intima in relation to death following myocardial infarction. Smith EB; Ashall C Atherosclerosis; 1985 May; 55(2):171-86. PubMed ID: 4004989 [TBL] [Abstract][Full Text] [Related]
38. Mitogenic activity in human atherosclerotic lesions. Thompson WD; McGuigan CJ; Snyder C; Keen GA; Smith EB Atherosclerosis; 1987 Jul; 66(1-2):85-93. PubMed ID: 3632755 [TBL] [Abstract][Full Text] [Related]
39. A diazophenylthio-ether-IgG probe for analysing fibrin- and fibrinogen-related antigens. Kruskal JB; Maeder DL; Purves LR; Franks JJ; Kirsch RE S Afr Med J; 1987 Feb; 71(4):211-7. PubMed ID: 3824087 [TBL] [Abstract][Full Text] [Related]
40. [Analysis of the stability of the intermediate fibrin polymers formed in a fibrinogen-thrombin system]. Ugarova TP; Lugovskoĭ EV; Gorkun OV; Derzskaia SG Ukr Biokhim Zh (1978); 1983; 55(3):254-9. PubMed ID: 6868148 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]